JP2008535840A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008535840A5 JP2008535840A5 JP2008505477A JP2008505477A JP2008535840A5 JP 2008535840 A5 JP2008535840 A5 JP 2008535840A5 JP 2008505477 A JP2008505477 A JP 2008505477A JP 2008505477 A JP2008505477 A JP 2008505477A JP 2008535840 A5 JP2008535840 A5 JP 2008535840A5
- Authority
- JP
- Japan
- Prior art keywords
- source
- composition
- fat
- ratio
- carbohydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 41
- 235000019197 fats Nutrition 0.000 claims 30
- 102000004169 proteins and genes Human genes 0.000 claims 26
- 108090000623 proteins and genes Proteins 0.000 claims 26
- 150000001720 carbohydrates Chemical class 0.000 claims 19
- 235000021004 dietary regimen Nutrition 0.000 claims 10
- 208000024172 Cardiovascular disease Diseases 0.000 claims 8
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 8
- 235000020778 linoleic acid Nutrition 0.000 claims 8
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 8
- 238000009472 formulation Methods 0.000 claims 7
- 235000016709 nutrition Nutrition 0.000 claims 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 6
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims 6
- OSCCDBFHNMXNME-WDCZJNDASA-N (2s,3s,4r)-2-amino-4-hydroxy-3-methylpentanoic acid Chemical compound C[C@@H](O)[C@@H](C)[C@H](N)C(O)=O OSCCDBFHNMXNME-WDCZJNDASA-N 0.000 claims 6
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims 6
- 239000004475 Arginine Substances 0.000 claims 6
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims 6
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 6
- 240000006053 Garcinia mangostana Species 0.000 claims 6
- 235000017048 Garcinia mangostana Nutrition 0.000 claims 6
- 229920002907 Guar gum Polymers 0.000 claims 6
- 241000208680 Hamamelis mollis Species 0.000 claims 6
- 229920001202 Inulin Polymers 0.000 claims 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 6
- 241000498779 Myristica Species 0.000 claims 6
- 235000009421 Myristica fragrans Nutrition 0.000 claims 6
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims 6
- 235000019482 Palm oil Nutrition 0.000 claims 6
- 240000008474 Pimenta dioica Species 0.000 claims 6
- 235000006990 Pimenta dioica Nutrition 0.000 claims 6
- 241000235343 Saccharomycetales Species 0.000 claims 6
- 244000223014 Syzygium aromaticum Species 0.000 claims 6
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 6
- 150000005693 branched-chain amino acids Chemical class 0.000 claims 6
- 235000005487 catechin Nutrition 0.000 claims 6
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims 6
- 235000001368 chlorogenic acid Nutrition 0.000 claims 6
- 229940074393 chlorogenic acid Drugs 0.000 claims 6
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims 6
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims 6
- 229910052804 chromium Inorganic materials 0.000 claims 6
- 239000011651 chromium Substances 0.000 claims 6
- 229950001002 cianidanol Drugs 0.000 claims 6
- 235000017803 cinnamon Nutrition 0.000 claims 6
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims 6
- 235000021323 fish oil Nutrition 0.000 claims 6
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims 6
- 150000003271 galactooligosaccharides Chemical class 0.000 claims 6
- OSCCDBFHNMXNME-UHFFFAOYSA-N gamma-hydroxyisoleucine Natural products CC(O)C(C)C(N)C(O)=O OSCCDBFHNMXNME-UHFFFAOYSA-N 0.000 claims 6
- 229930195712 glutamate Natural products 0.000 claims 6
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 6
- 239000000665 guar gum Substances 0.000 claims 6
- 229960002154 guar gum Drugs 0.000 claims 6
- 235000010417 guar gum Nutrition 0.000 claims 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 6
- 229940029339 inulin Drugs 0.000 claims 6
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims 6
- 235000019136 lipoic acid Nutrition 0.000 claims 6
- 239000001702 nutmeg Substances 0.000 claims 6
- 239000002540 palm oil Substances 0.000 claims 6
- 229960002663 thioctic acid Drugs 0.000 claims 6
- 229910052720 vanadium Inorganic materials 0.000 claims 6
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 claims 6
- 229940118846 witch hazel Drugs 0.000 claims 6
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 claims 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims 5
- 229940107187 fructooligosaccharide Drugs 0.000 claims 5
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 4
- 239000008103 glucose Substances 0.000 claims 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 4
- 206010022489 Insulin Resistance Diseases 0.000 claims 3
- 230000000291 postprandial effect Effects 0.000 claims 3
- 201000004569 Blindness Diseases 0.000 claims 2
- 206010020772 Hypertension Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 102000004877 Insulin Human genes 0.000 claims 2
- 108090001061 Insulin Proteins 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 208000018262 Peripheral vascular disease Diseases 0.000 claims 2
- 208000017442 Retinal disease Diseases 0.000 claims 2
- 206010038923 Retinopathy Diseases 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 208000007536 Thrombosis Diseases 0.000 claims 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 208000029078 coronary artery disease Diseases 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 229940125396 insulin Drugs 0.000 claims 2
- 208000010125 myocardial infarction Diseases 0.000 claims 2
- 208000031225 myocardial ischemia Diseases 0.000 claims 2
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 230000001934 delay Effects 0.000 claims 1
- 235000012054 meals Nutrition 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66863305P | 2005-04-06 | 2005-04-06 | |
| US60/668,633 | 2005-04-06 | ||
| PCT/US2006/012576 WO2006108008A2 (en) | 2005-04-06 | 2006-04-04 | A method and composition for nutritionally improving glucose control and insulin action |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013028114A Division JP2013100353A (ja) | 2005-04-06 | 2013-02-15 | グルコース制御およびインスリン作用を栄養的に改善するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008535840A JP2008535840A (ja) | 2008-09-04 |
| JP2008535840A5 true JP2008535840A5 (enExample) | 2009-05-28 |
| JP5788631B2 JP5788631B2 (ja) | 2015-10-07 |
Family
ID=36661519
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008505477A Expired - Lifetime JP5788631B2 (ja) | 2005-04-06 | 2006-04-04 | グルコース制御およびインスリン作用を栄養的に改善するための方法および組成物 |
| JP2013028114A Withdrawn JP2013100353A (ja) | 2005-04-06 | 2013-02-15 | グルコース制御およびインスリン作用を栄養的に改善するための方法および組成物 |
| JP2015146014A Pending JP2015187182A (ja) | 2005-04-06 | 2015-07-23 | グルコース制御およびインスリン作用を栄養的に改善するための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013028114A Withdrawn JP2013100353A (ja) | 2005-04-06 | 2013-02-15 | グルコース制御およびインスリン作用を栄養的に改善するための方法および組成物 |
| JP2015146014A Pending JP2015187182A (ja) | 2005-04-06 | 2015-07-23 | グルコース制御およびインスリン作用を栄養的に改善するための方法および組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8067359B2 (enExample) |
| EP (3) | EP1868454B1 (enExample) |
| JP (3) | JP5788631B2 (enExample) |
| CN (2) | CN105394748A (enExample) |
| AU (2) | AU2006231557B2 (enExample) |
| BR (1) | BRPI0608610A2 (enExample) |
| CA (1) | CA2601427C (enExample) |
| DK (1) | DK1868454T3 (enExample) |
| ES (1) | ES2419205T3 (enExample) |
| IL (1) | IL186005A0 (enExample) |
| MX (1) | MX2007012450A (enExample) |
| PT (1) | PT1868454E (enExample) |
| RU (1) | RU2421076C2 (enExample) |
| SG (1) | SG161234A1 (enExample) |
| WO (1) | WO2006108008A2 (enExample) |
| ZA (1) | ZA200707825B (enExample) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8283327B2 (en) | 2005-03-19 | 2012-10-09 | Kneller Bruce W | Palatinose for enhancing dietary supplement and pharmaceutical delivery |
| DK1868454T3 (da) * | 2005-04-06 | 2013-04-02 | Nestec Sa | Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning |
| WO2007140230A2 (en) * | 2006-05-26 | 2007-12-06 | Nestec S.A. | Methods of use and nutritional compositions of touchi extract |
| WO2008054193A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Nutritional products that comprise saccharide oligomers |
| KR101243406B1 (ko) * | 2008-01-09 | 2013-03-13 | 뉴트리 가부시키가이샤 | 암 화학 요법시에 일어나는 산화 스트레스 및/또는 부작용의 경감 혹은 암 화학 요법시의 영양 상태를 개선하기 위한 조성물 |
| US8071143B2 (en) * | 2008-04-02 | 2011-12-06 | Brandeis University | Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances |
| ES2583602T3 (es) * | 2008-05-07 | 2016-09-21 | Vegenat, S.A. | Mezcla de hidratos de carbono y su utilización para preparar un producto destinado a la alimentación oral o enteral |
| WO2009135959A1 (es) * | 2008-05-07 | 2009-11-12 | Katry Inversiones, S.L. | Producto alimenticio para la nutrición por vía enteral u oral del paciente diabético |
| US9345731B2 (en) | 2008-08-27 | 2016-05-24 | Pt. Dexa Medica | Herbal extract as sensitivity enhancer toward insulin and antidiabetes |
| CA2744100C (en) | 2008-10-21 | 2020-06-30 | The General Hospital Corporation | Cell transplantation |
| US8114445B2 (en) * | 2008-11-07 | 2012-02-14 | Reliv International Inc. | Dietary supplement for promoting wellness and weight loss and methods of administering the same |
| US20100179089A1 (en) * | 2009-01-13 | 2010-07-15 | Deutz Nicolaas E P | Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly |
| SG10201901259RA (en) | 2009-02-24 | 2019-03-28 | Ritter Pharmaceuticals Inc | Prebiotic formulations and methods of use |
| EP2411033B1 (en) | 2009-03-24 | 2015-03-04 | Universiti Putra Malaysia | Anti-diabetic nutraceutical composition from palm leaf extract |
| EP2311486A1 (en) * | 2009-10-07 | 2011-04-20 | Nestec S.A. | GLP-2 for use in intestine and muscle recovery |
| WO2012161670A2 (en) | 2010-04-07 | 2012-11-29 | Incube Labs, Llc | Method for treating diabetes and other glucose regulation disorders using stem cells |
| US20130202733A1 (en) * | 2010-07-14 | 2013-08-08 | Suedzucker Aktiengesellschaft Mannheim/Ochsenfurt | Isomaltulose for use in enhancing mental performance |
| KR101809301B1 (ko) | 2010-08-06 | 2018-01-18 | 더 제너럴 하스피털 코포레이션 두잉 비즈니스 애즈 매사츄세츠 제너럴 하스피털 | 세포 처리 시스템 및 장치 |
| CN101926431A (zh) * | 2010-08-23 | 2010-12-29 | 贵阳高新创嘉创业服务有限公司 | 一种具有保健功能的组合物及其制备方法和用途 |
| CN102007952A (zh) * | 2010-09-26 | 2011-04-13 | 深圳职业技术学院 | 营养棒及其制备方法 |
| PH12014500268A1 (en) * | 2011-08-16 | 2014-03-31 | Abbott Lab | Nutritional compositions comprising a soluble viscous fiber and a polyphenol-containing plant extract |
| US20150017309A1 (en) * | 2012-03-13 | 2015-01-15 | Sapporo Holdings Limited | Nutritionally balanced food or beverage product |
| WO2013173719A1 (en) * | 2012-05-18 | 2013-11-21 | Metaproteomics, Llc | Phytonutrient compositions and methods of use |
| WO2014124140A1 (en) | 2013-02-06 | 2014-08-14 | Brandeis University | Treatment of dna damage and mitochondrial dysfunction using palm fruit juice |
| AU2014284399B2 (en) | 2013-07-01 | 2017-10-26 | University Of Southern California | Fasting condition as dietary treatment of diabetes |
| ITMI20131467A1 (it) * | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
| WO2015074102A1 (en) * | 2013-11-19 | 2015-05-28 | Omniblend Innovation Pty Ltd | Composition and method for control of post-prandial glucose |
| WO2015109231A1 (en) * | 2014-01-17 | 2015-07-23 | Cornell University | Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists |
| US11191755B2 (en) | 2014-01-17 | 2021-12-07 | Cornell University | Compositions and methods for providing cardioprotective effects |
| MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
| JP2019504073A (ja) * | 2016-01-12 | 2019-02-14 | ユニバーシティ オブ サザン カリフォルニア | 多発性骨髄腫及び他のがんに対する食事療法としての長期断食模倣の使用 |
| IT201600083376A1 (it) | 2016-08-08 | 2018-02-08 | Sofar Spa | Uso di probiotici per aumentare l’assorbimento proteico |
| ITUA20164188A1 (it) | 2016-06-08 | 2017-12-08 | Sofar Spa | Nuovo uso medico di probiotici |
| EP3468670B1 (en) | 2016-06-10 | 2023-12-13 | University of Copenhagen | Predetermined diet for use in inducing weight loss and preventing weight gain |
| WO2017213961A1 (en) * | 2016-06-10 | 2017-12-14 | Gelesis Llc | Methods of inducing weight loss, treating obesity and preventing weight gain |
| CN106490614A (zh) * | 2016-10-31 | 2017-03-15 | 北京万源普达医疗科技有限公司 | 一种组合物及其作为糖尿病全营养配方食品的应用 |
| IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
| IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| JP7136807B2 (ja) | 2017-04-17 | 2022-09-13 | ザ・ユニバーシティ・オブ・シカゴ | ヒトの健康及び疾患の治療用途向けの短鎖脂肪酸の腸への送達用ポリマー材料 |
| US12110562B2 (en) | 2017-06-01 | 2024-10-08 | University Of Copenhagen | Compositions and methods for predicting and promoting weight loss |
| SG11202001142VA (en) | 2017-08-14 | 2020-03-30 | Axcella Health Inc | Amino acid compositions for the treatment of liver disease |
| US10596136B2 (en) | 2018-06-20 | 2020-03-24 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
| US11576403B2 (en) * | 2018-12-13 | 2023-02-14 | Societe Des Produits Nestle S.A. | Methods for enhancing metabolic health in an animal |
| CN109528734A (zh) * | 2019-01-24 | 2019-03-29 | 华纳时代健康科技（武汉）股份有限公司 | 一种复合营养组合物及其制备方法 |
| CN110200276B (zh) * | 2019-06-27 | 2023-04-07 | 刘东波 | 基于中药营养的组合物 |
| US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
| CN116209738B (zh) | 2020-09-01 | 2026-03-13 | 国际壳牌研究有限公司 | 发动机油组合物 |
| CN114631628A (zh) * | 2020-12-15 | 2022-06-17 | 中国科学院上海营养与健康研究所 | 一种增加血液fgf21浓度的方法 |
| CN114794487A (zh) * | 2021-01-22 | 2022-07-29 | 中国科学院上海营养与健康研究所 | 一种治疗糖尿病的方法 |
| CN113785915A (zh) * | 2021-08-05 | 2021-12-14 | 中山大学 | 一种甜味敏感的食物配方及其动物模型的构建方法 |
| CN113521277A (zh) * | 2021-08-27 | 2021-10-22 | 四川力量科技有限公司 | 一种康复糖尿病的产品及其制备方法 |
| CN116473125A (zh) * | 2022-01-17 | 2023-07-25 | 内蒙古伊利实业集团股份有限公司 | 一种缓释碳水组合物以及应用 |
| CN116549428B (zh) * | 2023-06-20 | 2025-05-16 | 郑州大学 | 4-羟基异亮氨酸的新用途 |
| WO2026038577A1 (ja) * | 2024-08-15 | 2026-02-19 | 太陽化学株式会社 | 飲食品摂取後の血中アミノ酸または消化管ホルモン濃度制御用組成物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8317248D0 (en) * | 1983-06-24 | 1983-07-27 | Wyeth John & Brother Ltd | Fat compositions |
| US6140304A (en) * | 1988-09-28 | 2000-10-31 | Eicotech Corporation | Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia |
| CA2173780A1 (en) * | 1995-06-01 | 1996-12-02 | Randy Grote | Method for providing nutrition in a variety of compositional forms |
| MY115050A (en) * | 1995-10-16 | 2003-03-31 | Mead Johnson Nutrition Co | Diabetic nutritional product having controlled absorption of carbohydrate |
| DK0780055T3 (da) * | 1995-10-27 | 2003-03-24 | Nestle Sa | Nærende kaffesammensætning |
| ES2179156T3 (es) | 1996-11-20 | 2003-01-16 | Nutricia Nv | Composicion nutricional que incluye grasas para el tratamiento del sindrome metabolico. |
| EP1310173B2 (en) | 1997-06-23 | 2014-12-31 | Société des Produits Nestlé S.A. | Composition for providing nutrition to diabetics |
| US5932258A (en) * | 1998-04-06 | 1999-08-03 | The Iams Company | Composition and process for improving glucose metabolism in companion animals |
| JP2000264844A (ja) * | 1999-01-11 | 2000-09-26 | Otsuka Pharmaceut Factory Inc | 腎疾患患者用栄養組成物 |
| US6440931B1 (en) * | 1999-02-23 | 2002-08-27 | Natural Corporation | Conjugated linoleic acid in treatment and prophylaxis of diabetes |
| US6592863B2 (en) * | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
| WO2002064809A2 (en) * | 2001-02-09 | 2002-08-22 | Unilever N.V. | Process for the preparation of one or more statins by fermentation |
| US6605310B2 (en) * | 2001-06-06 | 2003-08-12 | Nestec S.A. | Calorically dense liquid oral supplement |
| MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
| DK1643861T3 (da) * | 2003-07-15 | 2011-07-25 | Nestec Sa | Fiber- og kalorierig flydende næringssammensætning til tarmsundhed hos ældre patienter |
| DK1868454T3 (da) * | 2005-04-06 | 2013-04-02 | Nestec Sa | Sammensætning til ernæringsmæssig forbedring af glucosekontrol og insulinvirkning |
-
2006
- 2006-04-04 DK DK06749290.0T patent/DK1868454T3/da active
- 2006-04-04 CN CN201510501576.0A patent/CN105394748A/zh active Pending
- 2006-04-04 WO PCT/US2006/012576 patent/WO2006108008A2/en not_active Ceased
- 2006-04-04 ES ES06749290T patent/ES2419205T3/es not_active Expired - Lifetime
- 2006-04-04 MX MX2007012450A patent/MX2007012450A/es active IP Right Grant
- 2006-04-04 EP EP06749290A patent/EP1868454B1/en not_active Revoked
- 2006-04-04 CN CNA2006800167910A patent/CN101175416A/zh active Pending
- 2006-04-04 BR BRPI0608610-1A patent/BRPI0608610A2/pt not_active Application Discontinuation
- 2006-04-04 JP JP2008505477A patent/JP5788631B2/ja not_active Expired - Lifetime
- 2006-04-04 SG SG201002347-1A patent/SG161234A1/en unknown
- 2006-04-04 RU RU2007140731/13A patent/RU2421076C2/ru not_active IP Right Cessation
- 2006-04-04 EP EP10004583A patent/EP2241195A1/en not_active Withdrawn
- 2006-04-04 CA CA2601427A patent/CA2601427C/en not_active Expired - Lifetime
- 2006-04-04 US US11/910,817 patent/US8067359B2/en active Active
- 2006-04-04 PT PT67492900T patent/PT1868454E/pt unknown
- 2006-04-04 AU AU2006231557A patent/AU2006231557B2/en not_active Expired
- 2006-04-04 EP EP10004584A patent/EP2243383A3/en not_active Withdrawn
-
2007
- 2007-09-13 ZA ZA200707825A patent/ZA200707825B/xx unknown
- 2007-09-17 IL IL186005A patent/IL186005A0/en unknown
-
2010
- 2010-07-12 AU AU2010202933A patent/AU2010202933A1/en not_active Abandoned
-
2011
- 2011-07-22 US US13/188,911 patent/US8697630B2/en not_active Expired - Lifetime
-
2013
- 2013-02-15 JP JP2013028114A patent/JP2013100353A/ja not_active Withdrawn
-
2015
- 2015-07-23 JP JP2015146014A patent/JP2015187182A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2421076C2 (ru) | Способ и композиция для улучшения с помощью питания регуляции глюкозы и действия инсулина | |
| Choi et al. | Effect of carbohydrate-restricted diets and intermittent fasting on obesity, type 2 diabetes mellitus, and hypertension management: consensus statement of the Korean Society for the Study of Obesity, Korean Diabetes Association, and Korean Society of Hypertension | |
| US10646462B2 (en) | Compositions and methods for producing elevated and sustained ketosis | |
| ES2700463T3 (es) | Uso de aspartato para regular los niveles de glucosa en sangre | |
| ZA200505860B (en) | Compositions comprising fatty acids and amino acids | |
| EP2241196B2 (en) | Nutritional supplement comprising oligosaccharides and cysteine for treating hiv | |
| JP2013139470A (ja) | ロイシンに富む組成物 | |
| JP2009511576A5 (enExample) | ||
| WO2008149802A1 (ja) | アンドログラホリドを有効成分とする抗疲労剤及び経口組成物 | |
| Petyaev et al. | Whey protein lycosome formulation improves vascular functions and plasma lipids with reduction of markers of inflammation and oxidative stress in prehypertension | |
| US20090082249A1 (en) | Nutritional supplement for a category of hiv patients | |
| WO2008058358A3 (en) | Descriptive report of the patent of invention of the medicament 'rosuvastatin + metformin' in combined form for cardiovascular diseases. | |
| Lata Kanyal et al. | Status of vitamin b12 in type 2 diabetes mellitus patients taking metformin based oral hypoglycemic agent-a cross sectional study | |
| JP5808772B2 (ja) | 肝細胞内のミトコンドリアの活性化方法 | |
| MY143549A (en) | Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases | |
| WO2009096772A1 (en) | Composition for stimulating natural killer cell activity | |
| CN109419817B (zh) | 戈氏副拟杆菌用于降低胰岛素抗性及提升葡萄糖耐受性的用途 | |
| US20130289119A1 (en) | Formulation comprising arginine, use and preparation thereof | |
| JP6258943B2 (ja) | Ｈｍｂおよびａｔｐの組成物ならびに使用方法 | |
| Koikawa et al. | Delayed-onset muscle injury and its modification by wheat gluten hydrolysate | |
| Brănişteanu | The Amazing History of Methotrexate–75 Years Later from its Discovery, Still the “Golden Standard” Therapy | |
| WO2007070355A3 (en) | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes | |
| Kaur et al. | In-vitro modulation of glucose and lipid metabolism by Lentinula edodes extracts in obesity and type 2 diabetes models | |
| Aubuchon et al. | Supervised short-term nutrition and exercise promotes weight loss in overweight and obese patients with polycystic ovary syndrome | |
| JP2006076919A (ja) | 肥満予防・改善剤 |